Physician profile
Guy E Mcclary
NPI 1912168378
$12,856.31
in general payments reported to CMS, 2019-2025
66 companies · $1,769 in 2025
The $1,769 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,701 · 2020: $1,639 · 2021: $1,735 · 2022: $1,768 · 2023: $1,961 · 2024: $2,284 · 2025: $1,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,013.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,822.10 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,412.17 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Abbvie INC. | $1,060.08 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $949.22 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $944.44 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $813.36 | 2019-2025 | |
| Amgen INC. | $426.41 | 2019-2025 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $423.09 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $365.86 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $341.68 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $312.35 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Esperion Therapeutics, INC. | $267.53 | 2020-2025 | Nexletol |
| Amarin Pharma, INC. | $249.65 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $245.25 | 2019-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $167.57 | 2021-2025 | Freestyle Libre 3 |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $167.18 | 2024-2025 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $158.39 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $149.09 | 2023-2025 | Gemtesa |
| Seqirus USA INC | $143.64 | 2022-2025 | Flucelvax Quadrivalent, Fluad Quadrivalent, Fluad |
| Bayer Healthcare Pharmaceuticals INC. | $143.16 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $132.09 | 2019-2024 | Eliquis |
| Antares Pharma, INC. | $129.65 | 2021-2025 | Xyosted |
| Exact Sciences Corporation | $126.39 | 2024-2025 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $117.81 | 2020-2024 | Linzess |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $114.19 | 2024-2025 | Caplyta |
| Allergan, INC. | $112.04 | 2020 | |
| Daiichi Sankyo INC. | $106.07 | 2023-2024 | Injectafer |
| Shield Therapeutics INC | $104.90 | 2022-2025 | |
| Astellas Pharma US INC | $92.76 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $87.02 | 2022 | |
| Axsome Therapeutics, INC. | $78.23 | 2024-2025 | Auvelity |
| Sanofi Pasteur INC. | $77.94 | 2019-2024 | |
| Insulet Corporation | $77.49 | 2025 | Omnipod |
| Dexcom, INC. | $72.77 | 2022-2025 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $71.58 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $71.41 | 2020-2023 | |
| Boston Scientific Corporation | $66.88 | 2020-2025 | Watchman Flx |
| Sunovion Pharmaceuticals INC. | $54.81 | 2021-2022 | |
| Eisai INC. | $46.96 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $43.35 | 2020-2021 | |
| Kaleo, INC. | $42.09 | 2019 | |
| Nevro Corp. | $34.96 | 2023-2024 | Senza |
| Biohaven Pharmaceuticals, INC. | $33.33 | 2020-2021 | |
| Mylan Specialty L.P. | $30.21 | 2019-2020 | |
| Novavax INC | $25.07 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Scilex Pharmaceuticals INC. | $24.56 | 2024 | |
| Clarus Therapeutics INC. | $24.16 | 2021 | |
| Horizon Therapeutics Plc | $23.67 | 2019 | |
| Phathom Pharmaceuticals, INC. | $23.25 | 2025 | Voquezna |
| Hologic Sales and Service, LLC | $21.35 | 2022 | |
| Dynavax Technologies Corporation | $19.68 | 2025 | Heplisav-B |
| Impel Pharmaceuticals INC. | $18.33 | 2022 | |
| Corium, LLC | $17.86 | 2023 | Adlarity |
| Xeris Pharmaceuticals, INC. | $17.62 | 2025 | Gvoke Hypopen |
| Genentech USA, INC. | $15.36 | 2021 | |
| Edwards Lifesciences Corporation | $15.10 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Arbor Pharmaceuticals, INC. | $14.85 | 2019 | |
| Upsher-Smith Laboratories LLC | $14.79 | 2021 | |
| Halozyme INC | $14.20 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $13.49 | 2021 | |
| Cvrx, INC. | $13.26 | 2024 | Barostim Neo System |
| Hikma Pharmaceuticals USA | $12.76 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.45 | 2020 | |
| Vistapharm, INC. | $11.44 | 2021 | |
| Cashflow Solutions, LLC | $9.41 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Cequr Corporation | $7.50 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Mcclary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.